Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,125 public trials 393 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

NCT05783297

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • AIDS Healthcare Foundation Fort Lauderdale, Florida, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Howard Brown Health Chicago, Illinois, United States
  • Eskenazi Health Indianapolis, Indiana, United States
View Trial Details
Completed

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

NCT04502030

Conditions
Agammaglobulinemia, Blood Protein Disorders, Chronic Disease, +18 more
Locations
  • Octapharma Research Site St. Petersburg, Florida, United States
  • Octapharma Research Site Columbus, Georgia, United States
  • Octapharma Research Site Macon, Georgia, United States
  • Octapharma Research Site New Orleans, Louisiana, United States
View all 84 locations
View Trial Details
Completed

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

NCT05819775

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • Donald S. Levy M.D. Orange, California, United States
  • Raffi Tachdjian MD, Inc. Santa Monica, California, United States
View all 13 locations
View Trial Details
Completed

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

NCT04739059

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • Little Rock Allergy & Asthma Clinic Little Rock, Arkansas, United States
View all 44 locations
View Trial Details
Completed

Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

NCT04983030

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more
Locations
  • UCLA CARE (Center for AIDs Research and Education) Los Angeles, California, United States
  • Orlando Immunology Center Orlando, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Washington University Clinical Trials Unit St Louis, Missouri, United States
View Trial Details
Completed

Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants

NCT04484337

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site Las Vegas, Nevada, United States
  • GSK Investigational Site Berlin, New Jersey, United States
  • GSK Investigational Site Austin, Texas, United States
View Trial Details

Related conditions